Vysis ALK Break Apart FISH Probe Kit - Indonesia BPOM Medical Device Registration
Vysis ALK Break Apart FISH Probe Kit is a medical device registered with Indonesia's BPOM (Badan Pengawas Obat dan Makanan) under Analysis ID AKL 20304021800. The device is manufactured by ABBOTT MOLECULAR INC. from United States, and is classified as Risk Class Kelas Resiko : C. The authorized representative in Indonesia is PT. SCIENCEWERKE.
This page provides comprehensive regulatory information including complete registration details, manufacturer information, authorized representative details, product classification, and related products. Pure Global AI offers free access to 67,600+ Indonesia medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.
Risk Classification
Product Class
Kelas : 2
Manufacturer
ABBOTT MOLECULAR INC.Country of Origin
United States
Authorized Representative
PT. SCIENCEWERKEAR Address
Jl.Palmerah Barat No.25
Registration Date
May 29, 2024
Expiry Date
Dec 31, 2026
Product Type
Immunology Laboratory Equipment and Reagents
Automated fluorescence in situ hybridization (FISH) enumeration systems
Invitro Diagnostics
DAPI I Counterstain 2x500 ยตl (1000 ng/mL)
DAPI II Counterstain 2 x 500 ยตL (125 ng/mL)
ABBOTT NP-40
20X SSC
Vysis Paraffin Pretreatment IV & Post-Hybridization Wash Buffer Kit
ABBOTT RealTime HCV Genotype II Control Kit
Vysis CEP X SpetrumOrange /Y SpectrumGreen DNA Probe Kit
ABBOTT RealTime HCV Genotype II Amplification Reagent Kit
PATHVYSION HER-2 DNA Probe Kit
Vysis CLL FISH Probe Kit
ALLPLEXโข Respiratory Panel 1A
SEEGENE INC.
ALLPLEXโข GI-Parasite Assay
SEEGENE INC.
ALLPLEXโข GI-Bacteria(II) Assay
SEEGENE INC.
MGI Nucleic Acid Extraction Kit
WUHAN MGI TECH CO.,LTD
Allplexโข GI-Virus Assay
SEEGENE INC.
AllplexTM GI-Bacteria (I) Assay
SEEGENE INC.
ALLPLEXโข Meningitis-B Assay
SEEGENE INC.
ALLPLEXโข Meningitis-V1 Assay
SEEGENE INC.
ALLPLEXโข Meningitis-V2 Assay
SEEGENE INC.
AllplexTM Respiratory Panel 3
SEEGENE INC.

